NO20025150L - 2-acylindolderivater og deres anvendelse som antitumormidler - Google Patents

2-acylindolderivater og deres anvendelse som antitumormidler

Info

Publication number
NO20025150L
NO20025150L NO20025150A NO20025150A NO20025150L NO 20025150 L NO20025150 L NO 20025150L NO 20025150 A NO20025150 A NO 20025150A NO 20025150 A NO20025150 A NO 20025150A NO 20025150 L NO20025150 L NO 20025150L
Authority
NO
Norway
Prior art keywords
antitumor agents
acylindole derivatives
acylindole
derivatives
antitumor
Prior art date
Application number
NO20025150A
Other languages
English (en)
Norwegian (no)
Other versions
NO20025150D0 (no
Inventor
Thomas Beckers
Silke Baasner
Thomas Klenner
Siavosh Mahboobi
Herwig Pongratz
Markus Frieser
Harald Hufsky
Joerg Hockemeyer
Heinz-Herbert Fiebig
Angelika Burger
Frank-D Boehmer
Original Assignee
Baxter Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2000120852 external-priority patent/DE10020852A1/de
Priority claimed from DE2001102629 external-priority patent/DE10102629A1/de
Application filed by Baxter Healthcare Sa filed Critical Baxter Healthcare Sa
Publication of NO20025150D0 publication Critical patent/NO20025150D0/no
Publication of NO20025150L publication Critical patent/NO20025150L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20025150A 2000-04-28 2002-10-25 2-acylindolderivater og deres anvendelse som antitumormidler NO20025150L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE2000120852 DE10020852A1 (de) 2000-04-28 2000-04-28 2-Acryl-indolderivate und deren Verwendung als Antitumormittel
DE2001102629 DE10102629A1 (de) 2001-01-20 2001-01-20 2-Acyl-indolderivate und deren Verwendung als Antitumormittel
PCT/EP2001/004783 WO2001082909A2 (de) 2000-04-28 2001-04-27 2-acyl-indolderivate und deren verwendung als antitumormittel

Publications (2)

Publication Number Publication Date
NO20025150D0 NO20025150D0 (no) 2002-10-25
NO20025150L true NO20025150L (no) 2002-12-16

Family

ID=26005501

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20025150A NO20025150L (no) 2000-04-28 2002-10-25 2-acylindolderivater og deres anvendelse som antitumormidler

Country Status (27)

Country Link
US (2) US20020091124A1 (zh)
EP (1) EP1276720B1 (zh)
JP (1) JP2004501092A (zh)
KR (1) KR20030024661A (zh)
CN (1) CN1286810C (zh)
AR (1) AR029915A1 (zh)
AT (1) ATE348805T1 (zh)
AU (1) AU783459B2 (zh)
BG (1) BG107309A (zh)
BR (1) BR0110414A (zh)
CA (1) CA2407677A1 (zh)
CZ (1) CZ20023544A3 (zh)
DE (1) DE50111690D1 (zh)
EE (1) EE200200607A (zh)
GE (1) GEP20063751B (zh)
HK (1) HK1054549B (zh)
HR (1) HRP20020940A2 (zh)
HU (1) HUP0300480A3 (zh)
IL (1) IL152477A0 (zh)
IS (1) IS6594A (zh)
MX (1) MXPA02010627A (zh)
NO (1) NO20025150L (zh)
NZ (1) NZ522246A (zh)
PL (1) PL358877A1 (zh)
RU (1) RU2002132253A (zh)
SK (1) SK15432002A3 (zh)
WO (1) WO2001082909A2 (zh)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003535078A (ja) 2000-05-31 2003-11-25 アストラゼネカ アクチボラグ 血管損傷活性のあるインドール誘導体
US7005445B2 (en) 2001-10-22 2006-02-28 The Research Foundation Of State University Of New York Protein kinase and phosphatase inhibitors and methods for designing them
DE10152306A1 (de) * 2001-10-26 2003-07-24 Asta Medica Ag 2-Acylindolderivate mit neuen therapeutisch wertvollen Eigenschaften
AU2003214462A1 (en) 2002-04-03 2003-10-13 Astrazeneca Ab Indole derivatives having anti-angiogenetic activity
TW200400177A (en) 2002-06-04 2004-01-01 Wyeth Corp 1-(Aminoalkyl)-3-sulfonylindole and-indazole derivatives as 5-hydroxytryptamine-6 ligands
UA78999C2 (en) 2002-06-04 2007-05-10 Wyeth Corp 1-(aminoalkyl)-3-sulfonylazaindoles as ligands of 5-hydroxytryptamine-6
SE0300908D0 (sv) * 2003-03-31 2003-03-31 Astrazeneca Ab Azaindole derivatives, preparations thereof, uses thereof and compositions containing them
CA2548172A1 (en) * 2003-12-04 2005-06-23 Vertex Pharmaceuticals Incorporated Quinoxalines useful as inhibitors of protein kinases
RU2006147278A (ru) 2004-06-09 2008-07-20 Глэксо Груп Лимитед (GB) Производные пирролопиридина
US20060074083A1 (en) * 2004-10-05 2006-04-06 Merz Pharma Gmbh & Co. Kgaa Cyclic and acyclic propenones for treating CNS disorders
US8278290B2 (en) * 2005-02-14 2012-10-02 Biononics Limited Tubulin polymerisation inhibitors
WO2006128184A2 (en) * 2005-05-20 2006-11-30 Alantos-Pharmaceuticals, Inc. Pyrimidine or triazine fused bicyclic metalloprotease inhibitors
US20070155738A1 (en) * 2005-05-20 2007-07-05 Alantos Pharmaceuticals, Inc. Heterobicyclic metalloprotease inhibitors
US7838542B2 (en) 2006-06-29 2010-11-23 Kinex Pharmaceuticals, Llc Bicyclic compositions and methods for modulating a kinase cascade
FR2950053B1 (fr) * 2009-09-11 2014-08-01 Fournier Lab Sa Utilisation de derives d'indole benzoique comme activateurs de nurr-1, pour le traitement de la maladie de parkinson
WO2014033497A1 (en) * 2012-08-27 2014-03-06 Centre National De La Recherche Scientifique 5-azaindole compounds with anticancer and antiangiogenic activities
US9353150B2 (en) 2012-12-04 2016-05-31 Massachusetts Institute Of Technology Substituted pyrazino[1′,2′:1 ,5]pyrrolo[2,3-b]-indole-1,4-diones for cancer treatment
WO2014144715A1 (en) 2013-03-15 2014-09-18 Memorial Sloan-Kettering Cancer Center Hsp90-targeted cardiac imaging and therapy
WO2016114816A1 (en) * 2015-01-18 2016-07-21 Sri International MAP4K4 (HGK) Inhibitors
CN104945376B (zh) * 2015-07-09 2017-03-15 安徽理工大学 一种3‑芳酰基吲哚化合物的合成方法
WO2017197045A1 (en) 2016-05-11 2017-11-16 Movassaghi Mohammad Convergent and enantioselective total synthesis of communesin analogs
CN107722013B (zh) * 2016-08-11 2021-01-12 中国科学院上海药物研究所 去氮嘌呤类化合物及其药物组合物、制备方法和用途
WO2018209239A1 (en) 2017-05-11 2018-11-15 Massachusetts Institute Of Technology Potent agelastatin derivatives as modulators for cancer invasion and metastasis
US10640508B2 (en) 2017-10-13 2020-05-05 Massachusetts Institute Of Technology Diazene directed modular synthesis of compounds with quaternary carbon centers
US11535634B2 (en) 2019-06-05 2022-12-27 Massachusetts Institute Of Technology Compounds, conjugates, and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines and uses thereof
US12030888B2 (en) 2021-02-24 2024-07-09 Massachusetts Institute Of Technology Himastatin derivatives, and processes of preparation thereof, and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3660430A (en) * 1969-11-04 1972-05-02 American Home Prod 2-substituted-3-arylindoles
US3838167A (en) * 1972-08-01 1974-09-24 Lilly Co Eli Process for preparing indoles
DK3375A (zh) * 1974-01-25 1975-09-15 Ciba Geigy Ag
US5436265A (en) * 1993-11-12 1995-07-25 Merck Frosst Canada, Inc. 1-aroyl-3-indolyl alkanoic acids and derivatives thereof useful as anti-inflammatory agents
AU721037B2 (en) * 1996-09-12 2000-06-22 Auckland Uniservices Limited Condensed N-acylindoles as antitumor agents
AP9801302A0 (en) * 1997-07-23 2000-01-23 Pfizer Indole compounds as anti-inflammatory/analgesic agents..

Also Published As

Publication number Publication date
EE200200607A (et) 2004-04-15
RU2002132253A (ru) 2004-07-10
US20030158216A1 (en) 2003-08-21
BG107309A (bg) 2003-09-30
PL358877A1 (en) 2004-08-23
EP1276720A2 (de) 2003-01-22
CN1286810C (zh) 2006-11-29
HUP0300480A3 (en) 2006-04-28
HK1054549A1 (en) 2003-12-05
EP1276720B1 (de) 2006-12-20
AU783459B2 (en) 2005-10-27
AU6898401A (en) 2001-11-12
CN1431997A (zh) 2003-07-23
CA2407677A1 (en) 2002-10-28
JP2004501092A (ja) 2004-01-15
SK15432002A3 (sk) 2004-01-08
MXPA02010627A (es) 2004-05-17
KR20030024661A (ko) 2003-03-26
NZ522246A (en) 2006-01-27
ATE348805T1 (de) 2007-01-15
GEP20063751B (en) 2006-02-27
HUP0300480A2 (hu) 2003-06-28
BR0110414A (pt) 2003-02-11
NO20025150D0 (no) 2002-10-25
IL152477A0 (en) 2003-05-29
AR029915A1 (es) 2003-07-23
CZ20023544A3 (cs) 2004-07-14
WO2001082909A3 (de) 2002-03-14
WO2001082909A2 (de) 2001-11-08
IS6594A (is) 2002-10-25
HRP20020940A2 (en) 2005-02-28
DE50111690D1 (de) 2007-02-01
US20020091124A1 (en) 2002-07-11
HK1054549B (zh) 2007-02-23

Similar Documents

Publication Publication Date Title
DK1204649T3 (da) Arylmethylcarbonylaminothiazolderivater og deres anvendelse som antitumormidler
NO20025150D0 (no) 2-acylindolderivater og deres anvendelse som antitumormidler
NO20021253L (no) Kinolylpropylpiperidinderivater og deres anvendelse som antibakterielle midler
NO20035366D0 (no) Benzoylsulfonamider og sulfonylbenzamidiner for anvendelse som antitumormidler
NO20025357L (no) Antranylamider og deres anvendelse som legemidler
DK1478629T3 (da) N-aryl-2-oxazolidinon-5-carboxamider og deres derivater og deres anvendelse som antibakterielle midler
DK1498413T3 (da) 4-aminopicolinater og deres anvendelse som herbicider
NO20020684D0 (no) Aminopyrazolderivater, fremgangsmåte for deres fremstilling og deres anvendelse som antitumormidler
NO20026010D0 (no) Substituerte quinazolinderivater og deres anvendelse som inhibitorer
DK1133477T3 (da) Substituerede benzimidazoler og deres anvendelse som parpinhibitorer
NO20033565L (no) Acylerte indanylaminer og deres anvendelse som farmasöytiske midler
DK1198454T3 (da) Multilinderivater og deres anvendelse som antibakterielle midler
DK1292604T3 (da) 2-Aminocarbonyl-9H-purinderivater
ATE288437T1 (de) Tetrahydro-heterocycloazepinyl-pyrimidin-deriva e
ATE298332T1 (de) Decahydro-isochinolinderivate
DK1280809T3 (da) Antitumorecteinascidinderivater
NO20031838D0 (no) Benzokazinonderivater, deres fremstilling og anvendelse
DK1387838T3 (da) Cyanoanthranylamid-derivater og deres anvendelse som lægemidler
NO20040210L (no) Fenylacetamido-tiazolderivater, fremgangsmate for deres fremstilling og deres anvendelse som antitumormidler
DK1265892T3 (da) Isothiazolderivater og deres anvendelse som pesticider
DK1322593T3 (da) O-substituerede-6-methyl-tramadol-derivater
DK1246791T3 (da) Aminomethyl-phenyl-cyklohexanonderivater
DE60117096D1 (de) Dihydroindol- und tetrahydrochinolinderivate
NO20025884D0 (no) 2-aminotiazolinderivater og deres anvendelse som NO- syntaseinhibitorer
DK1259515T3 (da) Thienopyridinderivater og deres anvendelse som antiinflammatoriske midler

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application